No more sitting with the school nurse, five Kleenex, head tilted back during recess. A startup with University of Wisconsin ties has launched a $25,000 Indiegogo campaign to bring over-the-counter nosebleed relief to patients with a topical gel that claims to stop the nosebleed in one minute.
Greg Dockter, a pharmacist, founded ByzMed LLC because he endures frequent nosebleeds himself and when a patient’s nose started bleeding at his pharmacy, he could only offer help by handing them a tissue. The product, DrXNoze, consists of a disposable swab with “natural” ingredients that “will make the blood clot faster and ingredients that will balance the mucus production of the nasal membrane.” That swab is inserted into the nose and placed on the problem area while the patient pinches her nose for a minute. The company targets consumers who have hypertension, take blood thinners, have allergies, use nasal steroids and so on.
The product has been “formulated with the assistance of the University of Wisconsin-Pharmacy School’s Lenor Zeeh Pharmaceutical Experimentation Station,” according to the site. The company is testing to see whether this product could be used to prevent nosebleeds.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The money will go toward final stability trials and product packaging. The product should be ready to launch in December 2013.
